Results of early endoscopic exam critical for assessment of Barrett's patients

February 14, 2019

A new study indicates that both high-grade abnormal cellular changes (dysplasia) and esophageal adenocarcinoma (a form of cancer) have increased in the last 25 years among people with a digestive condition known as Barrett's esophagus. The study report, Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades, is published in the February issue of GIE: Gastrointestinal Endoscopy, the peer-reviewed journal of the American Society for Gastrointestinal Endoscopy (ASGE).

The Barrett's Esophagus Study looked at more than 3,600 patients at multiple healthcare centers who had Barrett's esophagus (BE). This is a condition in which the normal tissue that lines the esophagus (the tube that carries food from the mouth to the stomach) develops abnormal changes. A significant percentage of people who have chronic symptoms of gastroesophageal reflux disease (GERD) will develop Barrett's esophagus.

The researchers looked at the index endoscopy findings of BE patients.

Endoscopy is a medical procedure in which doctors insert a tube with a camera at the end into the patient's digestive tract to look for visible problems or changes. Sometimes the doctor can treat a problem area while doing the endoscopy. The "index endoscopy" is one that is performed when a patient first complains of symptoms that need to be checked. The index endoscopy may be used later to compare to the results of successive endoscopies if those are recommended.

In this study, the researchers reviewed the index endoscopy results of the BE patients to determine the proportions of those with no dysplasia, low-grade dysplasia (LGD), high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC).

A look at these patients' records over 25 years indicated that over time, there was an increase in the mean age of patients with BE, and the proportion of males diagnosed with BE also increased. The proportion of patients who had low-grade dysplasia had remained stable, but there was a 148 percent increase of those with high-grade dysplasia and a 112% increase of those with EAC. Higher-grade dysplasia presents a higher risk for developing into cancer. There also was a marked increase in the number of visible lesions (areas of damaged tissue) detected during the endoscopy.

There was a decrease in the mean "BE length," meaning how many centimeters of the lining of the esophagus appear to be changed.

According to the study authors, these results suggest that the prevalence of HGD and EAC has significantly increased over the past 25 years despite a decrease in BE length during the same period. This increase parallels an increase in the detection of visible lesions, suggesting that a careful examination at the index endoscopy is crucial.
-end-
This study was made available online in October 2018 ahead of final publication in print in February 2019.

Editor's note for trade press: Dr. Madhav Desai discusses "Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past two decades: data from a multicenter U.S. consortium." https://youtu.be/vw2_5VyEwHc

American Society for Gastrointestinal Endoscopy

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.